Dr. D. CBD

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
Jul
17
2018

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

Cloning and pharmacological characterization of the dog cannabinoid CB₂receptor.
May
28
2018

Cloning and pharmacological characterization of the dog cannabinoid CB₂receptor.

Written by Dr D / CB2 Receptor
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
May
28
2018

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.

Written by Dr D / CB2 Receptor, Pain
Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
May
28
2018

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

CB2 receptors as new therapeutic targets for liver diseases.
May
28
2018

CB2 receptors as new therapeutic targets for liver diseases.

Identification and functional characterization of brainstem cannabinoid CB2 receptors.
May
28
2018

Identification and functional characterization of brainstem cannabinoid CB2 receptors.

Cannabinoid type 2 receptor as a target for chronic – pain.
May
28
2018

Cannabinoid type 2 receptor as a target for chronic – pain.

Written by Dr D / CB2 Receptor, Pain
CB2 receptor-mediated migration of immune cells: it can go either way.
May
28
2018

CB2 receptor-mediated migration of immune cells: it can go either way.

Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands.
May
28
2018

Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands.